Advisory Committee for Injury Prevention and Control, the Science and Program Review Subcommittee: Meeting, 27501-27502 [E6-7209]

Download as PDF Federal Register / Vol. 71, No. 91 / Thursday, May 11, 2006 / Notices DC 20405; stanley.langfeld@gsa.gov, (202) 501–1737. Please cite FMR Bulletin 2005–03. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Dated: May 5, 2006. John G. Sindelar Acting Associate Administrator, Office of Governmentwide Policy. [FR Doc. E6–7221 Filed 5–10–06; 8:45 am] Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Intervention Research Grants To Promote the Health of People With Disabilities (Panel A), RFA–DD06–004 BILLING CODE 6820–RH–S In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting: DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panels (SEP): Childhood Immunization, RFA–IP06–005, IP06– 007, and IP06–008 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following meeting: cchase on PROD1PC60 with NOTICES Name: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Childhood Immunization, RFA– IP06–005, IP06–007, and IP–06–008. Time and Date: 1 a.m.–4 p.m., June 16, 2006 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: To conduct expert review of scientific merit of grant applications in response to Childhood Immunization, RFA–IP06–005, IP06–007, and IP06–008. For Further Information Contact: George Bockosh, B.S., M.S., Scientific Review Administrator, Pitt Building 20, Room 313, MS P05, Pittsburgh, PA 15236, Telephone 412–386–6465. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: May 5, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–7208 Filed 5–10–06; 8:45 am] BILLING CODE 4163–18–P VerDate Aug<31>2005 16:29 May 10, 2006 Jkt 208001 Name: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Intervention Research Grants to Promote the Health of People with Disabilities (Panel A), RFA–DD06–004. Time and Date: 11:30 p.m.–5:30 p.m., June 12, 2006 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: To conduce expert review of scientific merit of research applications in response to: Intervention Research Grants to Promote the Health of People with Disabilities, (Panel A), RFA– DD06–004. For Further Information Contact: Juliana Cyril, PhD, Scientific Review Administrator, CDC, 1600 Clifton Road NE., Mailstop D72, Atlanta, GA 30333, Telephone 404–639– 0920. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: May 5, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–7212 Filed 5–10–06; 8:45 am] 27501 Control and Prevention (CDC) announces the following meeting. Name: Healthcare Infection Control Practices Advisory Committee (HICPAC). Times and Dates: 8:30 a.m.–5 p.m., June 1, 2006; 8:30 a.m.–4 p.m., June 2, 2006. Place: CDC Roybal Campus, Bldg. 19, Auditorium B3, 1600 Clifton Road, Atlanta, GA 30333. Status: Open to the public, limited only by the space available. Purpose: The committee is charged with providing advice and guidance to the Secretary, Department of Health and Human Services, the Assistant Secretary for Health, the Director, CDC, and the Director, National Center for Infectious Diseases (NCID), regarding: (1) The practice of hospital infection control; (2) strategies for surveillance, prevention, and control of infections (e.g., nosocomial infections), antimicrobial resistance, and related events in settings where healthcare is provided; and (3) periodic updating of guidelines and other policy statements regarding prevention of healthcare-associated infections and healthcare-related conditions. Matters To Be Discussed: Informatics and healthcare-associated infections; process for updating guidelines; updates on pandemic flu; updates on antimicrobial resistance and updates on CDC activities of interest to the committee. Agenda items are subject to change as priorities dictate. For Further Information Contact: Harriette Lynch, Committee Management Specialist, HICPAC, Division of Healthcare Quality Promotion, NCID, CDC, l600 Clifton Road, NE, M/S A–07, Atlanta, Georgia 30333, telephone 404–639–4035. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: May 5, 2006. Alvin Hall, M.S., Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–7211 Filed 5–10–06; 8:45 am] BILLING CODE 4163–18–P BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Healthcare Infection Control Practices Advisory Committee (HICPAC); Meeting In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 Centers for Disease Control and Prevention Advisory Committee for Injury Prevention and Control, the Science and Program Review Subcommittee: Meeting In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) E:\FR\FM\11MYN1.SGM 11MYN1 27502 Federal Register / Vol. 71, No. 91 / Thursday, May 11, 2006 / Notices cchase on PROD1PC60 with NOTICES announces the following subcommittee and committee meetings. Name: Science and Program Review Subcommittee (SPRS). Times and Dates: 6:30 p.m.–9:30 p.m., June 12, 2006. 8 a.m.–11:30 a.m., June 13, 2006. Place: Doubletree Hotel Atlanta, 3342 Peachtree Road, NE., Atlanta, GA 30326. Status: Open: 6:30 p.m.–7 p.m., June 12, 2006. Closed: 7 p.m.–9:30 p.m., June 12, 2006. Closed: 8 a.m.–10 a.m., June 13, 2006. Open: 10 a.m.–11:30 a.m., June 13, 2006. Purpose: The SPRS provides advice on the needs, structure, progress and performance of programs of the National Center for Injury Prevention and Control (NCIPC), as well as second-level scientific and programmatic review for applications for research grants, cooperative agreements, and training grants related to injury control and violence prevention, and recommends approval of projects that merit further consideration for funding support. The SPRS also advises on priorities for research to be supported by contracts, grants, and cooperative agreements and provides concept review of program proposals and announcements. Matters to be Discussed: The subcommittee will meet June 12–13 to provide a secondary review, discuss, and evaluate grant applications and cooperative agreements received in response to eight Request for Applications (RFAs) related to the following individual applications: #06001, Research Grants to Prevent Unintentional Injuries; #06002, Dissertation Grant Awards for Violence Injury Research in Minority Communities; #06003, Research Grants to Describe Traumatic Brain Injury Consequences; #06004, Grants for ViolenceRelated Injury Prevention Research; #06005, Research Grants for the Care of the Acutely Injured; #06006, Using Technology to Augment Effectiveness of Parenting Programs; #06007, Evaluation of CommunityBased Approaches to Increasing Seat Belt Use among Adolescents and Their Passengers; #06008, Urban Partnership Academic Centers of Excellence. This portion of the meeting (7 p.m.–9:30 p.m., June 12, 2006, and 8 a.m.– 10 a.m., June 13, 2006) will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5, U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Agenda items are subject to change as priorities dictate. Name: Advisory Committee for Injury Prevention and Control. Times and Dates: 1 p.m.–5:30 p.m., June 13, 2006. 8:30 a.m.–12 p.m., June 14, 2006. Place: Doubletree Hotel Atlanta, 3342 Peachtree Road, NE., Atlanta, GA 30326. Status: Closed: 1 p.m.–1:45 p.m., June 13, 2006. Open: 1:45 p.m.–5:30 p.m., June 13, 2006. Open: 8:30 a.m.–12 p.m., June 14, 2006. Purpose: The committee advises and makes recommendations to the Secretary, Department of Health and Human Services, the Director, CDC, and the Director, NCIPC, regarding feasible goals for the prevention and control of injury. The committee makes recommendations regarding policies, VerDate Aug<31>2005 16:29 May 10, 2006 Jkt 208001 strategies, objectives, and priorities, and reviews progress toward injury prevention and control. Matters to be Discussed: From 1 p.m.–1:45 p.m., June 13, 2006 the full committee will vote on the results of secondary review. This portion of the meeting will be closed to the public in accordance with provisions set forth in section 552(b)(4) and (6), title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Following the closed session, the meeting will open to the public. Agenda items are subject to change as priorities dictate. For Further Information Contact: Ms. Louise Galaska, Executive Secretary, ACIPC, NCIPC, CDC, 4770 Buford Highway, NE., M/ S K02, Atlanta, Georgia 30341–3724, telephone (770) 488–4694. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: May 5, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E6–7209 Filed 5–10–06; 8:45 am] (71 FR 7052), the agency announced that the proposed information collection had been submitted to OMB for review and clearance under 44 U.S.C. 3507. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910–0183. The approval expires on April 30, 2009. A copy of the supporting statement for this information collection is available on the Internet at https://www.fda.gov/ ohrms/dockets. Dated: May 4, 2006. Jeffrey Shuren, Assistant Commissioner for Policy. [FR Doc. E6–7157 Filed 5–10–06; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. 2005N–0157] BILLING CODE 4163–18–P Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Adverse Drug Experience Reporting DEPARTMENT OF HEALTH AND HUMAN SERVICES AGENCY: Food and Drug Administration ACTION: [Docket No. 2005N–0425] SUMMARY: The Food and Drug Administration (FDA) is announcing that a collection of information entitled ‘‘Adverse Drug Experience Reporting’’ has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT: Karen L. Nelson, Office of Management Programs (HFA–250), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301–827–1482. SUPPLEMENTARY INFORMATION: In the Federal Register of February 7, 2006 (71 FR 6281), the agency announced that the proposed information collection had been submitted to OMB for review and clearance under 44 U.S.C. 3507. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910–0230. The approval expires on April 30, 2009. A copy of the supporting statement for this information collection is available on the Internet at https://www.fda.gov/ ohrms/dockets. Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; General Administrative Procedures: Citizen Petitions; Petition for Reconsideration or Stay of Action; Advisory Opinions AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing that a collection of information entitled ‘‘General Administrative Procedures: Citizen Petitions; Petition for Reconsideration or Stay of Action; Advisory Opinions’’ has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT: Jonna Capezzuto, Office of Management Programs (HFA–250), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301–827–4659. SUPPLEMENTARY INFORMATION: In the Federal Register of February 10, 2006 PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 Food and Drug Administration, HHS. E:\FR\FM\11MYN1.SGM Notice. 11MYN1

Agencies

[Federal Register Volume 71, Number 91 (Thursday, May 11, 2006)]
[Notices]
[Pages 27501-27502]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-7209]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee for Injury Prevention and Control, the Science 
and Program Review Subcommittee: Meeting

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC)

[[Page 27502]]

announces the following subcommittee and committee meetings.

    Name: Science and Program Review Subcommittee (SPRS).
    Times and Dates: 6:30 p.m.-9:30 p.m., June 12, 2006. 8 a.m.-
11:30 a.m., June 13, 2006.
    Place: Doubletree Hotel Atlanta, 3342 Peachtree Road, NE., 
Atlanta, GA 30326.
    Status: Open: 6:30 p.m.-7 p.m., June 12, 2006. Closed: 7 p.m.-
9:30 p.m., June 12, 2006. Closed: 8 a.m.-10 a.m., June 13, 2006. 
Open: 10 a.m.-11:30 a.m., June 13, 2006.
    Purpose: The SPRS provides advice on the needs, structure, 
progress and performance of programs of the National Center for 
Injury Prevention and Control (NCIPC), as well as second-level 
scientific and programmatic review for applications for research 
grants, cooperative agreements, and training grants related to 
injury control and violence prevention, and recommends approval of 
projects that merit further consideration for funding support. The 
SPRS also advises on priorities for research to be supported by 
contracts, grants, and cooperative agreements and provides concept 
review of program proposals and announcements.
    Matters to be Discussed: The subcommittee will meet June 12-13 
to provide a secondary review, discuss, and evaluate grant 
applications and cooperative agreements received in response to 
eight Request for Applications (RFAs) related to the following 
individual applications: 06001, Research Grants to Prevent 
Unintentional Injuries; 06002, Dissertation Grant Awards 
for Violence Injury Research in Minority Communities; 
06003, Research Grants to Describe Traumatic Brain Injury 
Consequences; 06004, Grants for Violence-Related Injury 
Prevention Research; 06005, Research Grants for the Care of 
the Acutely Injured; 06006, Using Technology to Augment 
Effectiveness of Parenting Programs; 06007, Evaluation of 
Community-Based Approaches to Increasing Seat Belt Use among 
Adolescents and Their Passengers; 06008, Urban Partnership 
Academic Centers of Excellence. This portion of the meeting (7 p.m.-
9:30 p.m., June 12, 2006, and 8 a.m.-10 a.m., June 13, 2006) will be 
closed to the public in accordance with provisions set forth in 
Section 552b(c)(4) and (6), Title 5, U.S.C., and the Determination 
of the Director, Management Analysis and Services Office, CDC, 
pursuant to Public Law 92-463.
    Agenda items are subject to change as priorities dictate.

    Name: Advisory Committee for Injury Prevention and Control.
    Times and Dates: 1 p.m.-5:30 p.m., June 13, 2006. 8:30 a.m.-12 
p.m., June 14, 2006.
    Place: Doubletree Hotel Atlanta, 3342 Peachtree Road, NE., 
Atlanta, GA 30326.
    Status: Closed: 1 p.m.-1:45 p.m., June 13, 2006. Open: 1:45 
p.m.-5:30 p.m., June 13, 2006. Open: 8:30 a.m.-12 p.m., June 14, 
2006.
    Purpose: The committee advises and makes recommendations to the 
Secretary, Department of Health and Human Services, the Director, 
CDC, and the Director, NCIPC, regarding feasible goals for the 
prevention and control of injury. The committee makes 
recommendations regarding policies, strategies, objectives, and 
priorities, and reviews progress toward injury prevention and 
control.
    Matters to be Discussed: From 1 p.m.-1:45 p.m., June 13, 2006 
the full committee will vote on the results of secondary review. 
This portion of the meeting will be closed to the public in 
accordance with provisions set forth in section 552(b)(4) and (6), 
title 5 U.S.C., and the Determination of the Director, Management 
Analysis and Services Office, CDC, pursuant to Public Law 92-463. 
Following the closed session, the meeting will open to the public.
    Agenda items are subject to change as priorities dictate.
    For Further Information Contact: Ms. Louise Galaska, Executive 
Secretary, ACIPC, NCIPC, CDC, 4770 Buford Highway, NE., M/S K02, 
Atlanta, Georgia 30341-3724, telephone (770) 488-4694.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: May 5, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
 [FR Doc. E6-7209 Filed 5-10-06; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.